BusinessNew York Medical College and Touro College of Pharmacy Team to Offer Pharmacogenomics CME Course Sponsored by Admera HealthBy Nasdaq OMXAug 8, 2017, 1:59 PM UTC
BusinessEarth Science Tech, Inc. Signs Contract with Absolu to Advance Phase-2 Rollout on MSN-2 Medical DeviceBy Nasdaq OMXAug 3, 2017, 12:35 PM UTC
BusinessAXIM Biotech Enters Clinical Study Agreement with University of British Columbia to Begin Clinical Trial On CBD Chewing Gum For Treatment of Drug-Related PsychosisBy Nasdaq OMXAug 2, 2017, 1:01 PM UTC
BusinessEarth Science Tech Inc. Signs Contract with CDBQ to Advance Phase-2 Rollout on it’s CBD PatentsBy Nasdaq OMXAug 1, 2017, 12:25 PM UTC
BusinessMadrigal Pharmaceuticals Completes Enrollment in Phase 2 Proof-of-Concept Study with MGL-3196 for Treatment of NASHBy Nasdaq OMXAug 1, 2017, 11:30 AM UTC
BusinessEarth Science Tech, Inc. Finalizes New KannaBidioiD Product Labels & Updates ShareholdersBy Nasdaq OMXJul 27, 2017, 12:25 PM UTC
BusinessAXIM Biotech Enters Services Agreement With Israel-Based CRO to Begin Clinical POC Study on CBD and Gabapentin Chewing Gum for Treatment of Restless Leg SyndromeBy Nasdaq OMXJul 20, 2017, 1:00 PM UTC
BusinessReal Endpoints Appoints Jane F. Barlow, MD, EVP and Chief Clinical OfficerBy Nasdaq OMXJul 17, 2017, 2:00 PM UTC
